Oncology Clinical Trials
Oncology trials don’t fail at the database. They fail between visits. Delve Health runs oncology trials end-to-end—sites, patients, data, and follow-through—so endpoints remain interpretable.
Delve Health combines CRO-style delivery with a real-time compliance operating system: site enablement, patient concierge follow-through, eCOA/ePRO, wearables, device logistics, and analysis readiness. We manage what happens between visits—where oncology endpoints are most likely to degrade.
Compliance focus
90–98%
Diary / ePRO completion (program-dependent)
Retention lift
2–3×
Improvement when follow-through is owned
Real-time oversight
Live
Risk surfaced early, not at DBL
Why Delve
Traditional CROs manage visits. Delve manages what happens between visits.
Oncology execution breaks down in the gaps: symptom burden, missed diaries, device friction, late follow-up, and silent missingness. We close those gaps with a single operating model that includes people, workflows, and real-time evidence trails.
Strong on project structure
- Monitoring and reporting cadence
- Vendor coordination and oversight
- Site contact and issue routing
- Standardized operating procedures
Risk: between-visit compliance and patient follow-through becomes fragmented across sites, tools, and busy teams.
More data, more fragmentation
- Multiple vendors for eCOA, wearables, logistics
- Data arrives late and disconnected
- Gaps become “monitoring findings” later
- Sites absorb the burden of follow-up
Risk: accountability is unclear; compliance becomes retrospective and expensive to fix.
Owned compliance + owned follow-through
- Real-time visibility into adherence and missingness
- Concierge team intervenes as issues appear
- Device telemetry monitoring + rapid troubleshooting
- Evidence trails for actions, escalations, and resolutions
Outcome: higher usable data yield, fewer deviations, lower site burden, and stronger retention.
How We Engage
Flexible delivery models—from prime execution to CRO integration.
Full-Service Oncology Delivery (Prime)
Delve leads study execution end-to-end with an oncology operating model built around compliance, retention, and real-time oversight. Specialty functions can be delivered directly or through Delve-led partners as scoped.
- Start-up + site coordination
- Patient operations + concierge follow-through
- eCOA/wearables/logistics + live oversight
Hybrid With Your CRO
Keep your CRO for monitoring/EDC and plug Delve in as the compliance and patient execution layer. We reduce missingness, improve follow-through, and give your team live visibility.
- Delve owns adherence + participant support
- Telemetry monitoring + escalation pathways
- Cleaner data at lock with fewer late fixes
Site Network Enablement
We support and activate site networks by offloading patient follow-up, device workflows, and operational burden—so sites can focus on care and enrollment.
- Coordinator relief: reminders, rescheduling, training
- Pre-screening support (as scoped)
- Study-wide oversight dashboards for networks
Protocol-to-Analysis
End-to-end oncology delivery—mapped to what sponsors actually need.
“End-to-end” is not a slogan. It is a lifecycle with ownership and evidence trails—from protocol operationalization through analysis readiness and close-out.
Step 1
Protocol operationalization
- SOA converted into executable workflows and visit windows
- Risk register focused on oncology failure points
- Escalation pathways and intervention rules defined
Step 2
Feasibility + site network plan
- Site/network strategy aligned to indication and burden
- Start-up coordination and readiness tracking
- Training and enablement workflows for sites
Step 3
Recruitment support (as scoped)
- Referral handling and pre-screening assistance
- Patient outreach scripts and follow-up cadence
- Escalation of qualified candidates to sites
Step 4
Onboarding + training
- Patient training, device setup, and troubleshooting
- Multilingual support and ongoing engagement
- Visit confirmations and between-visit coordination
Step 5
Conduct: compliance operations
- Real-time adherence monitoring (tasks + telemetry)
- Concierge outreach when compliance drifts
- Documented interventions and outcomes
Step 6
Safety operations + escalation
- Symptom capture triggers routed per protocol
- Structured escalation to site/sponsor teams
- Audit-ready documentation of follow-up actions
Step 7
Data quality + reconciliation
- Continuous QC and missingness surveillance
- Wear-time/signal health monitoring and remediation
- Reconciliation across eCOA, wearables, and exports
Step 8
Analysis readiness + close-out
- Analysis-ready exports and documented handling rules
- Close-out evidence package: compliance + continuity
- Support for interim looks and endpoint performance review (as scoped)
Oncology Capabilities
Execution built for oncology realities.
Symptom-heavy protocols
Oncology protocols demand consistent patient-reported information across fatigue, pain, nausea, sleep, and QoL.
- Protocol-driven ePRO/eCOA schedules with visit windows
- Automated reminders plus human follow-through
- Escalation workflows when concerning patterns appear
Wearables + digital measures
When digital measures are used, the real risk is missingness and signal loss—not the sensor itself.
- Device logistics + provisioning workflows
- Telemetry: sync, battery, data continuity monitoring
- Signal health checks and rapid remediation
Site relief + network performance
Sites cannot absorb more follow-up work. We take operational weight off coordinators while keeping evidence trails intact.
- Reminders, rescheduling, training, participant questions
- Pre-screening assistance and patient qualification (as scoped)
- Study-wide oversight dashboards for sponsors and networks
Deliverables
What you receive when Delve runs oncology execution.
- Operational study plan + oncology execution risk register
- Participant engagement plan + scripts + escalation pathways
- Device deployment plan + accountability + replacement workflows
- Data quality plan: missingness rules, telemetry checks, reconciliation approach
- Weekly risk report: compliance, retention, and site/network performance
- Close-out evidence package: intervention logs, compliance summary, data continuity report
From raw signals to analysis-ready evidence
We do not simply “collect data.” We operationalize adherence, document interventions, and reduce silent missingness— so your team sees cleaner datasets and fewer late-cycle surprises.
- Continuous QC and outlier/missingness surveillance
- Documentation of interventions (what happened, when, why, outcome)
- Reconciliation across digital sources and exports (as scoped)
- Readiness support for interim looks and endpoint reviews (as scoped)
If you already have DM/biostats partners, Delve integrates and strengthens the operational evidence chain.
Planning an oncology study?
If your endpoints depend on consistent between-visit behavior—diaries, symptoms, devices, follow-up—Delve is built to protect that evidence chain. We can lead end-to-end execution or integrate with your CRO to improve compliance and retention.